Datexim Company Profile: Funding, Investors & Partnerships

Datexim

Datexim created a new solution to decrease the number of missed cases while drastically reducing the time needed to screen a slide. The first AI-based image analysis solution for cervical cancer screening is on the market thanks to the CE certification of CytoProcessor, and we go on with passion to improve our solutions. We also have the ambition to give access to diagnosis and prevention to low-resource countries thanks to a dedicated platform.Datexim created a new solution to decrease the number of missed cases while drastically reducing the Show More

Alpha Score

58.7

Total Funding$ 4.13 M